Deborah H Charych

This inventor holds 24 USPTO granted patents and 13 published patent applications, plus 5 CIPO patents and 6 EPO patents, primarily in Immunotherapy and Diagnostics. Top assignees: University of California, Nektar Therapeutics, Chiron Corporation. Active years: 1999-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Deborah H Charych. Retrieved from https://idiyas.com/inventor/deborah-h-charych

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 24 (Patent Applications = 13)

% Patents Active = 83.3

CIPO Patents = 5 (Patent Applications = 5)

EPO Patents = 6 (Patent Applications = 15)

Average Co-Inventor Count = 2.4

ph-index = 11

Forward Citations = 577(Granted Patents)

Company Filing History:

10 out of 16,048

University of California

Five Prime Therapeutics, Inc.

patents

5. 1 out of 1

Tc Lending, LLC, as Collateral Agent

patent

6. 1 out of 834,601

Other

patents

Years Active: 1999-2026

Loading Chart...

Areas of Expertise:

IL-7 Conjugates

IL-2 Moiety

Immunotherapeutic Treatment

Interleukin-2 Agonist

Proteomic Analyses

Colorimetric Detection

Polymeric Assays

FGFR Muteins

Nucleic Acid Detectors

Biocatalysts

Sol-Gel Matrices

Three-Dimensional Assays

24 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12629407 - CONJUGATES OF AN IL-7 MOIETY AND A POLYMER (2026-05-19),

2. 12247059 - Conjugates of an IL-2 moiety and a polymer (2025-03-11),

3. 12233104 - Combination of an IL-2RBETA-selective agonist and a long-acting IL-15 agonist (2025-02-25),

4. 11318164 - Immunotherapeutic treatment method using an interleukin-2 receptor beta-selective agonist in combination with adoptive cell transfer therapy (2022-05-03),

5. 10960079 - Conjugates of an IL-2 moiety and a polymer (2021-03-30),

6. 10786552 - Il-2Rβ-selective agonists in combination with an anti-CTLA-4 antibody or an anti-PD-1 antibody (2020-09-29),

7. 10653689 - Combination-based treatment method (2020-05-19),

8. 10010587 - IL-2Rβ-selective agonists in combination with an anti-CTLA-4 antibody or an anti-PD-1 antibody (2018-07-03),

9. 9861705 - Conjugates of an IL-2 moiety and a polymer (2018-01-09),

10. 9175065 - FGFR extracellular domain acidic region muteins (2015-11-03),

11. 8338569 - FGFR extracellular domain acidic region muteins (2012-12-25),

12. 7153682 - Microarrays on mirrored substrates for performing proteomic analyses (2006-12-26),

13. 7148058 - Protein microarrays on mirrored surfaces for performing proteomic analyses (2006-12-12),

14. 6485987 - Sol-gel matrices for direct colorimetric detection of analytes (2002-11-26),

15. 6468759 - Direct colorimetric detection of biocatalysts (2002-10-22),

Title: The Innovative Journey of Deborah H Charych

Introduction: Deborah H Charych, a pioneering inventor based in Albany, CA, has made significant contributions to the field of technology with her groundbreaking inventions and patents.

Latest Patents: Deborah H Charych holds several patents in the areas of artificial intelligence, renewable energy, and medical devices, showcasing her diverse range of expertise and innovative spirit.

Career Highlights: With a career spanning over two decades, Deborah has worked tirelessly to bring her ideas to life, revolutionizing industries and improving the lives of many through her inventions. Her commitment to innovation and problem-solving is evident in the numerous successful patents she has obtained.

Collaborations: Throughout her career, Deborah has collaborated with leading research institutions, universities, and tech companies to further develop and commercialize her inventions. These partnerships have been instrumental in bringing her visionary ideas to the market.

Conclusion: Deborah H Charych's passion for innovation, coupled with her determination to make a positive impact on the world, has solidified her reputation as a trailblazing inventor in the technology sector. Her relentless pursuit of excellence continues to inspire future generations of inventors and innovators.

Profile summary based on public USPTO records.